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Abstract 
Post-operative pain management in transplant recipients undergoing incisional herniorraphy is 
challenging. Historically limited to intravenous or oral opioids, alternatives including transversus 
abdominus plane (TAP) block catheters and thoracic epidural catheters have been introduced . The 
aim of this study was to determine whether TAP catheters and thoracic epidural analgesia 
significantly impacted on postoperative pain and opioid usage in transplant recipients undergoing 
incisional hernia repair. Methods: This single center retrospective study included 154 patients 
undergoing incisional hernia repair from January 2011 to June 2015. Of these, 56 received epidurals, 
51 received TAP catheters, and 47 received no intervention. Results: demographic profiles were 
comparable among the three groups including type of previous transplant and type of hernia surgery. 
Thoracic epidural analgesia was associated with lower median, mean, and maximum pain scores 
(P<0.001) and less opioid requirement (P<0.001). There was no difference in pain scores and opioid 
usage among the TAP catheter and no intervention groups. There was no difference in time to first 
flatus or first bowel movement, length of hospital stay, individual opioid-related side effects, and 
adverse reactions among the 3 groups. Conclusion: This study supports the use of thoracic epidural 
analgesia in patients undergoing hernia repair after transplant surgery. 
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Introduction 
An abdominal organ transplant operation typically involves a long incision, followed by high dose 
induction immunosuppression; both of which are considered risk factors for an incisional hernia.1 
Unsurprisingly, herniorrhaphy is commonly required after transplantation, with some reporting an 
incidence as high as 35% following liver and pancreas transplants (kidney transplant incisions, being 
lateral, have a much lower incidence).1 One challenge of incisional hernia repairs is intense 
postoperative pain.1,2,3 Parenteral pain control is the cornerstone of pain management in those cases, 
but it can be associated with ileus, respiratory depression, pneumonia, and aspiration.3,4,5,6 Increased 
opioid use has been associated with an increase in length of ICU and hospital stay.7 On the other hand, 
inadequate pain control can lead to pneumonia, delayed wound healing, and increased length of 
stay.8,9  In transplant patients, these problems are magnified by immunosuppression, making the issue 
of adequate pain control key in avoiding complications in this patient population.1 
 
To address these challenges, we began using continuous TAP (transversus abdominis plane) blocks 
for post-herniorraphy analgesia in 2013.  However, even in patients undergoing a laparoscopic hernia 
repair with small incisions, we noticed that analgesia with continuous TAP blocks was not meeting 
the needs of our patients as well as we had hoped. This was most likely due to the underlying mesh 
size and the area of mesh fixation, which are much larger than the incision size. Also, liver transplant 
hernias, located in the upper abdomen, are poorly covered with a TAP block.  We therefore 
transitioned to offering thoracic epidural analgesia to this group of patients.  
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Epidural analgesia for post-operative pain control has been shown to decrease total opioid 
consumption.10, 11,12,13 However, epidural use is potentially problematic in immunosuppressed 
patients, due to the theoretical risk of meningitis, epidural abscess, or other infectious complications.14  
Overall, infectious complications associated with regional anesthesia are very rare events.15 Some 
studies report 1 infectious complication (nervous system infection, epidural abscess, etc) for every 
40,000 regional nerve blocks. Others report 1 infectious event per 100,000 blocks .16 Nevertheless, the 
possibility exists that the risk of these rare, but potentially devastating, infectious complications could 
be increased in an immunosuppressed patient population. Therefore, in setting up an epidural protocol 
for immunosuppressed patients, we considered avoidable factors that might increase infectious 
complications in immunosuppressed patients. 
 
First, in those rare cases of infection following regional anesthesia, duration of epidural placement 
appears to play a role.17 Therefore we usually limit epidural placement in immunosuppressed patients 
to four days. 
 
Second, the immunosuppression following transplantation is most intense in the early post-transplant 
period. Therefore we try to avoid hernia repair in the first 6 months post-transplant. After that period, 
the immunosuppression is much less intense. 
 
Third, the type of immunosuppression may affect the risk of complications. The infectious 
complications reported after epidural catheter placements are mainly bacterial. However, not all 
immunosuppression regimens are equally prone to bacterial infections, which are mainly the hallmark 
of corticosteroid based immunosuppression. In contrast, steroid-free immunosuppression tends to be 
associated with viral infections or other non-bacterial infections that would not be typical of an 
epidural catheter-associated infection. We reasoned that thoracic epidural catheters in transplant 
recipients on steroid-free immunosuppression have a reasonable risk-benefit profile. Of note, our 
institution’s long-term immunosuppression regimen is usually steroid-free. Another concern with 
immunosuppressive agent is wound healing. Our institution only uses rapamycin routinely for 
kidney/pancreas transplant patients. Liver and kidney transplant recipients do not receive long term 
rapamycin. For patients on rapamycin, we routinely convert the agent to mycophenolate prior to 
coming to the OR, due to concern with wound healing.  
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Finally, in order to minimize the risk of infectious complications, we place all of our epidural 
catheters in the operating room under sterile conditions. The anesthesiologists scrub and wear sterile 
gowns and gloves for all epidural catheter placements.   
 
Given the paucity of literature published to date on use of epidural analgesia in immunosuppressed 
patients, the primary aim of this study was to investigate the difference in postoperative pain intensity 
and opioid usage between organ transplant patients who underwent incisional hernia repair with 
epidural analgesia compared to those who received continuous TAP blocks and those who received no 
regional analgesia. Secondary aims of this study were to examine differences in time to first flatus and 
bowel movement, and opioid-related side effects (nausea, vomiting, respiratory depression, 
pneumonia, and aspiration) between patients who received epidural analgesia, continuous TAP 
blocks, or no regional analgesic intervention.  
 
Methods 
Indiana University Hospital is a large academic medical center where 40-50 herniorraphy operations 
are performed per year in patients who have undergone prior organ transplantation.  Following review 
and approval by the Indiana University institutional review board, we performed a retrospective chart 
review. All regional anesthesia procedures at our institution were done under supervision of an Acute 
Pain Service attending. All TAP catheters are done under ultrasound (US) visualization. After 
identifying the Transversus Abdominis Plane on US, the anesthesiologists will inject 0.2% 
ropivacaine into each TAP space. All patients will then have an elastomeric pain relief ball (OnQ) 
attached to the TAP catheter in PACU to provide continuous infusion. All thoracic epidurals are done 
in the operating room under sterile condition. We scrubbed, gowned, and gloved for all epidurals due 
to the immunosuppressive state on all these patients. The epidurals are placed between T8-T10 level. 
Standard epidural mix in our institution is bupivacaine 0.1%/hydromorphone 0.05mg/ml. All epidural 
infusions are started in PACU to provide continuous infusion. As far as pain scores and opioid usage, 
pain scores were evaluated every 6 hours in our institution using Visual Analog Scale (VAS). All 
recorded pain scores were collected and analyzed for daily mean, median, and maximum score. Daily 
opioid usage were also recorded and all opioid recorded were converted to IV morphine equivalent 
each day.  
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Study Population 
 
All solid organ transplant patients undergoing incisional hernia repair between January 1, 2011 and 
June 30, 2015 at Indiana University Hospital were identified using billing data and reviewed through 
medical records or Cerner/Care web according to inclusion and exclusion criteria. All post-transplant 
patients who underwent elective incisional hernia repair under general anesthesia were included. 
These patients all receive either a “Mercedes” (liver) or a midline (pancreas) incisions during their 
initial surgery. Patients with perioperative bowel or organ injury, recurrent ventral hernias, or 
incarcerated hernias were excluded. Further exclusion criteria included current daily opioid use, 
contraindications to morphine or hydromorphone, diagnosis of “chronic pain syndrome,” and a known 
history of substance abuse. Patients younger than 18 years of age were excluded. Overall, we 
collected data on 154 transplant recipients undergoing incisional hernia repair including 56 patients 
who had received epidural analgesia, 51 patients who had received continuous TAP blocks, and 47 
patients who had received no intervention.  
 
Data from the postoperative period was obtained from patient charts, anesthesia records, ICU notes, 
and the transplant registry. Demographic data was collected from patient electronic medical records. 
The data obtained included pain intensity scores from day 1 to day of discharge, opioid usage, time to 
first flatus, time to first bowel movement, length of hospital stay, and occurrence of opioid-related 
side effects including nausea, vomiting, respiratory depression, pneumonia, and aspiration.  
 
Statistical Analysis 
 
Demographic comparisons between the three groups were performed using a two-sample t-test for 
continuous variables and a chi-square test for categorical variables. The mean and standard error were 
calculated for all of the continuous endpoints (e.g. pain scores by day and across all days, time to first 
flatus, time to first bowel movement, length of stay) and frequency with percentage for categorical 
endpoints (e.g. opioid use, each type of opioid-related side effect).  
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A linear mixed model was performed to analyze pain scores over longitudinal data (7 days per 
patient). Median, mean, and maximum pain scores from potentially 12 pain scores per patient per day 
were first calculated and then used as outcomes.  
 
A linear regression model was used for analyzing the three cross-sectional outcomes, time to flatus, 
time to bowel movement, and length of hospital stay.  
 
Opioid-related side effect frequency was calculated based on the presence of opioid-related side 
effects on any day.  A logistic regression model was performed to investigate possible influential 
factors for the occurrence of opioid-related side effects.  
 
Patients’ age at surgery, BMI, type of transplant, duration of surgery, and amount of blood loss were 
included in all the statistical models. In addition, time effect –variable ‘countday’, was included in the 
mixed model for pain score analysis. For all calculations, p-values less than 0.05 were considered 
significant. All calculations and data analysis were performed using SAS statistical software version 
9.2 (SAS Institute Inc., Cary, NC). 
 
Results 
The patient demographics (Table 1) show that the patients in the 3 study groups (epidural, continuous 
TAP block, or no analgesic intervention) were similar with respect to age, gender, and BMI. 
Interestingly, patients who received epidural analgesia had significantly less intra-operative blood loss 
than those who did not have an epidural (P<0.001; Table 1). This is likely due to selection bias since 
epidural catheter placement is contraindicated in patients with coagulopathies. Patients rated their pain 
scores using a numerical rating scale. Patients who received epidural analgesia reported significantly 
lower median, mean, and maximum pain scores than those who did not have an epidural (P<0.001). 
Patients with epidural analgesia also used significantly less opioids (P<0.001). Tables 2, 3, and 4 
show the pain scores and opioid usage comparisons for the first, second, and third post-operative 
days, respectively. Patients who received epidural analgesia reported significantly lower median, 
mean, and maximum pain scores on each individual day (P<0.05; Tables 2, 3, 4). Patients who 
received epidural analgesia used significantly less opioids on post-operative day 1 (p<0.001; Table 2) 
and day 2 (p=0.014; Table 3). The difference in opioid usage between patients who received epidural 
analgesia and those who did not were not as significant by day 3 (p=0.084; Table 4), but continued the 
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trend of lower opioid consumption by patients who received epidural analgesia.  Data from later days 
were not analyzed as patients typically had their epidural or TAP block catheters removed on day 3.  
 
Patients in the epidural group did not show an increased in incidence of side effects when compared 
with the non-epidural group (Table 5). The time to first flatus, time to first BM, and hospital length of 
stay was not statistically significant among the groups as well (Table 6).  
 
Discussion 
This study was a retrospective analysis of pain control methods for organ transplant recipients who 
are undergoing hernia repair.  Our primary endpoints were pain scores and post-operative opioid 
consumption.  The patients who received epidural analgesia had a significant reduction of median and 
mean pain scores as well as opioid consumption compared to the patients in the other two groups.  
This shows that epidural analgesia is superior to either continuous TAP blocks or pain control without 
a regional analgesic intervention.  
 
With regard to our secondary endpoints, we hypothesized that an analgesic intervention which 
reduced oral and intravenous opioid consumption would reduce the incidence of side effects and 
complications associated with opioid analgesia.  We were interested to see that this hypothesis was 
not confirmed.  There was no significant difference in time to first flatus, time to first bowel 
movement, length of hospital stay, individual opioid-related side effects, or adverse reactions between 
those who received epidural analgesia and those who did not. Interestingly, we see a slightly higher 
hospital length of stay (though not statistically significant) in our epidural populations. This is likely 
due to selection bias since patients with very big complex hernias are not candidate for TAP catheters 
and will only be offered epidurals for their complex hernia repairs.  
 
Addressing the safety of epidural analgesia in this patient population, we noted that no major opioid-
related side effects were reported in any of the patients in the epidural group.  No infectious 
complications related to the analgesic intervention occurred in any of these immunosuppressed 
patients. 
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The strength of this retrospective study is that all hernia repairs are done by a single transplant 
surgeon here in our institution, hence there is no difference in surgical technique or perioperative 
management amongst the groups. Mesh size was based on overlap onto healthy tissues of at least 4cm 
all directions.  In addition, the entire incision was assessed for possible weakness or incipient hernia 
(“Swiss cheese hernia”).  In most cases, the entire incision was reinforced with mesh. Since transplant 
incisions are large regardless of whether it was a liver transplant or pancreas transplant, this usually 
meant using the largest piece of mesh available, tailored to the shape of the hernia defect and the 4 cm 
overlap all edges. Most common mesh sizes use for our hernia repair (liver, pancreas, or kidney) are 
30.5cm x 35.6cm and 25.4cm x 33cm.  
 
The limitations of this study include the fact that it was a retrospective case review study.  Due to this 
study design, postoperative nursing care and data entry was not standardized for all patients.  In 
addition, study blinding and randomization were not possible, resulting in possible bias. The study 
sample was modest, and the study may not have been adequately powered to reliably detect our 
secondary endpoints. We were also unable to detect the failure rate of either the epidural or the TAP 
catheters, since these data were not available in our electronic medical record.  
 
Conclusions 
Thoracic epidural catheter placement in transplant patients undergoing herniorraphy was introduced at 
Indiana University Hospital in order to improve post-operative analgesia.  For these patients, 
postoperative pain control has historically been limited to intravenous and oral opioids.  However, the 
use of opioids is associated with systemic opioid-related side effects, such as ileus and respiratory 
depression.  These side effects put patients at risk for suboptimal pain control and an increased length 
of hospital stay.  Using elastomeric pain pump devices for analgesia after hernia repair has not been 
shown to significantly decrease pain, opioid consumption, or length of hospital stay.18   Epidural 
analgesia has been shown to provide good postoperative pain relief both after open liver resection and 
live liver donation.19, 20 The use of epidural analgesia for post-operative pain control has also been 
found to reduce total opioid consumption. Our results expand upon these studies, showing the 
effectiveness of epidural analgesia in post-transplant populations. Our findings show that epidural 
analgesia was superior to continuous TAP block analgesia as well as analgesia with oral and 
parenteral medications. Epidural analgesia decreased post-operative pain scores and opioid usage for 
this group of patients.  
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We did not see a statistically significant difference in opioid-related side effects including ileus, 
aspiration, or respiratory depression between the three groups.  We had hypothesized that the opioid-
sparing effect of epidural analgesia would lead to a reduction in opioid-related side effects, but we did 
not observe this finding.  The size and design of the study may have been suboptimal for detecting 
these secondary endpoints. 
 
Although our number of patients in this study was small, we detected no infections related to the 
epidural or TAP block catheters in any of these immunosuppressed patients. Thus, our data support 
the usage of epidurals in immunosuppressed patients after organ transplant surgery. With the current 
opioid epidemics being declared a public health emergency, and the national movement towards 
decreasing opioid usage, our data further support the use of epidurals in this patient population.  
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Table 1. Summary Statistics of Patient Demographics  
   
Variables 
Total 
N=154(%) 
No Intervention 
N=47(%) 
Epidural 
N=56(%) 
TAP Catheter 
N=51(%) P Value 
Age on day of 
surgery 
    0.077 A 
Mean ± SE 54.3 ± 0.813 55.4 ± 1.32 55.8 ± 1.51 51.8 ± 1.30  
Median (min - max) 55 (26 - 81) 57 (30 - 78) 55.5 (26 - 81) 53 (32 - 77)  
Gender     0.116 C 
Male 103 (67) 37 (79) 35 (63) 31 (61)  
Female 51 (33) 10 (21) 21 (37) 20 (39)  
BMI     0.449 A 
Mean ± SE 30.6 ± 1.3 31.1 ± 0.8 32.2 ± 3.4 28.4 ± 0.7  
Median (min - max) 28.6 (17.6 - 
215.0) 
29.9 (20.9 - 
47.1) 
28.2 (17.6 - 
215.0) 
28.0 (19.2 - 
43.5) 
 
Type of Previous 
Transplant 
    0.002 C 
+
 
Liver 83 (54) 36 (77) 30 (53) 17 (33)  
Kidney 14 (9) 2 (4) 4 (7) 8 (16)  
Pancreas 25 (16) 2 (4) 11 (20) 12 (24)  
Pancreas/Kidney 32 (21) 7 (15) 11 (20) 14 (27)  
Duration of 
Surgery (minute) 
    0.002 A 
Mean ± SE 226 ± 6.43 258 ± 14.5 220 ± 7.39 204 ± 10.4  
Median (min - max) 209.5 (40 - 
471) 
250 (52 - 440) 209 (104 - 408) 199 (40 - 471)  
Blood_loss (ml)     <.001 A 
Mean ± SE 47.9 ± 6.0 83.4 ± 16.0 22.3 ± 3.1 43.3 ± 7.9  
Median (min - max) 20.0 (3.0 - 
600.0) 
50.0 (10.0 - 
600.0) 
10.0 (3.0 - 
100.0) 
20.0 (5.0 - 
300.0) 
 
Type_of_hernia     0.103 C 
Open 17 (11) 9 (19) 4 (7) 4 (8)  
Laparoscopic 137 (89) 38 (81) 52 (93) 47 (92)  
 
+Exact test 
AANOVA F-test; CChi-square test; KKruskal-Wallis test 
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Table 2. Pain score and Opioid usage comparison for day1 
 
   
Variables 
Total 
N=154(%) 
No Intervention 
N=47(%) 
Epidural 
N=56(%) 
TAP Catheter 
N=51(%) P Value 
Median_pain     0.100 A 
Mean ± SE 4.4 ± 0.2 4.8 ± 0.3 3.9 ± 0.3 4.7 ± 0.3  
Median (min - 
max) 
5.0 (0.0 - 10.0) 4.5 (1.0 - 10.0) 4.5 (0.0 - 9.0) 5.0 (0.0 - 8.0)  
Mean_pain     0.044 A 
Mean ± SE 4.5 ± 0.2 4.8 ± 0.3 3.9 ± 0.3 4.8 ± 0.2  
Median (min - 
max) 
4.6 (0.0 - 9.5) 4.7 (1.1 - 9.5) 4.1 (0.0 - 8.0) 5.0 (0.9 - 8.0)  
Max_pain     0.009 A 
Mean ± SE 6.5 ± 0.2 7.0 ± 0.3 5.7 ± 0.3 6.9 ± 0.3  
Median (min - 
max) 
7.0 (0.0 - 10.0) 7.0 (2.0 - 10.0) 6.0 (0.0 - 10.0) 7.0 (3.0 - 10.0)  
Ivmorphine     <.001 A 
Mean ± SE 4.6 ± 0.8 4.0 ± 1.0 1.1 ± 0.5 8.9 ± 2.0  
Median (min - 
max) 
0.0 (0.0 - 56.7) 0.0 (0.0 - 32.5) 0.0 (0.0 - 19.5) 5.0 (0.0 - 56.7)  
 
+Exact test 
AANOVA F-test; CChi-square test; KKruskal-Wallis test 
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Table 3. Pain score and Opioid usage comparison for day2 
 
   
Variables 
Total 
N=151(%) 
No Intervention 
N=47(%) 
Epidural 
N=55(%) 
TAP Catheter 
N=49(%) P Value 
Median_pain     0.002 A 
Mean ± SE 3.5 ± 0.2 3.9 ± 0.3 2.7 ± 0.3 4.0 ± 0.3  
Median (min - max) 4.0 (0.0 - 10.0) 4.0 (0.0 - 7.0) 3.0 (0.0 - 7.5) 4.0 (0.0 - 10.0)  
Mean_pain     0.004 A 
Mean ± SE 3.6 ± 0.2 4.0 ± 0.3 2.9 ± 0.3 4.0 ± 0.2  
Median (min - max) 3.8 (0.0 - 8.8) 4.1 (0.0 - 7.4) 2.6 (0.0 - 7.5) 4.1 (0.5 - 8.8)  
Max_pain     0.013 A 
Mean ± SE 5.5 ± 0.2 6.1 ± 0.3 4.7 ± 0.4 5.7 ± 0.3  
Median (min - max) 5.0 (0.0 - 10.0) 6.0 (0.0 - 10.0) 4.0 (0.0 - 10.0) 6.0 (1.0 - 10.0)  
Ivmorphine     0.014 A 
Mean ± SE 8.4 ± 1.8 8.3 ± 1.3 2.4 ± 0.9 15.2 ± 5.3  
Median (min - max) 2.5 (0.0 - 252.5) 8.0 (0.0 - 35.0) 0.0 (0.0 - 36.0) 6.0 (0.0 - 252.5)  
 
+Exact test 
AANOVA F-test; CChi-square test; KKruskal-Wallis test 
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Table 4. Pain score and Opioid usage comparison for day3 
 
   
Variables 
Total 
N=135(%) 
No Intervention 
N=44(%) 
Epidural 
N=51(%) 
TAP Catheter 
N=40(%) P Value 
Median_pain     0.018 A 
Mean ± SE 3.2 ± 0.2 3.7 ± 0.3 2.5 ± 0.3 3.6 ± 0.4  
Median (min - 
max) 
3.0 (0.0 - 10.0) 4.0 (0.0 - 8.0) 2.0 (0.0 - 8.0) 3.5 (0.0 - 10.0)  
Mean_pain     0.019 A 
Mean ± SE 3.3 ± 0.2 3.6 ± 0.3 2.6 ± 0.3 3.7 ± 0.3  
Median (min - 
max) 
3.4 (0.0 - 9.5) 3.8 (0.0 - 7.7) 2.4 (0.0 - 7.4) 3.8 (0.0 - 9.5)  
Max_pain     0.046 A 
Mean ± SE 5.0 ± 0.2 5.5 ± 0.3 4.3 ± 0.4 5.4 ± 0.4  
Median (min - 
max) 
5.0 (0.0 - 10.0) 5.0 (0.0 - 9.0) 4.0 (0.0 - 10.0) 5.0 (0.0 - 10.0)  
Ivmorphine     0.084 A 
Mean ± SE 12.7 ± 4.5 9.0 ± 1.8 4.2 ± 0.9 27.7 ± 14.7  
Median (min - 
max) 
3.3 (0.0 - 
585.0) 
5.5 (0.0 - 65.0) 0.0 (0.0 - 30.0) 5.8 (0.0 - 
585.0) 
 
 
+Exact test 
AANOVA F-test; CChi-square test; KKruskal-Wallis test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
                                                                                                                                                                                             
 
Table 5. Adverse Reaction Comparisons Between Two Groups 
 
     
Variables 
Total 
N=154(%) 
No epidural 
N=98(%) 
Epidural 
N=56(%) P Value 
Nausea 
(Promethazine, 
Ondansetron, etc) 
   0.215  
NO 131 (85) 86 (88) 45 (80)  
YES 23 (15) 12 (12) 11 (20)  
Vomit    1.000 
NO 150 (97) 95 (97) 55 (98)  
YES 4 (3) 3 (3) 1 (2)  
Respiratory 
Depression 
    
NO 154 (100) 98 (100) 56 (100)  
Naloxone given    0.364 
NO 153 (99) 98 (100) 55 (98)  
YES 1 (1) 0 (0) 1 (2)  
Pneumonia    0.364 
NO 153 (99) 98 (100) 55 (98)  
YES 1 (1) 0 (0) 1 (2)  
Aspiration    0.184 
NO 154 (100) 98 (100) 56 (100)  
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Table 6. Other outcome variable comparisons between three groups 
 
   
Variables 
Total 
N=154(%) 
No Intervention 
N=47(%) 
Epidural 
N=56(%) 
TAP Catheter 
N=51(%) P Value 
Time TO first 
flatus 
    0.104 A 
Mean ± SE 61.1 ± 2.36 68.3 ± 4.41 56.0 ± 3.72 60.5 ± 4.10  
Median (min - max) 59.9 (2.12 - 
148.2) 
70.2 (8.28 - 
148.1) 
55.6 (2.12 - 
105.3) 
58.6 (17.2 - 
127.4) 
 
Time TO first BM     0.416 A 
Mean ± SE 80.7 ± 2.6 86.0 ± 4.6 78.8 ± 3.2 78.0 ± 5.77  
Median (min - max) 77.1 (6.3 - 
271.7) 
83.9 (6. 3 - 
190.4) 
78.4 (39.6 - 
137.7) 
67.6 (39.3 - 
271.7) 
 
Length of hospital 
stay: 
    0.152 A 
Mean ± SE 7.54 ± 0.78 8.64 ± 2.05 8.58 ± 1.24 5.40 ± 0.39  
Median (min - max) 5.31 (2.1 - 98.2) 5.81 (3.0 - 98.2) 6.19 (2.9 - 52.4) 4.25 (2.1 - 14.3)  
 
+Exact test 
AANOVA F-test; CChi-square test; KKruskal-Wallis test 
 
 
